IBDEI0SD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13304,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,13304,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,13304,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,13305,0)
 ;;=R80.9^^53^589^89
 ;;^UTILITY(U,$J,358.3,13305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13305,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,13305,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,13305,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,13306,0)
 ;;=Z87.442^^53^589^77
 ;;^UTILITY(U,$J,358.3,13306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13306,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,13306,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,13306,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,13307,0)
 ;;=N18.1^^53^589^13
 ;;^UTILITY(U,$J,358.3,13307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13307,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,13307,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,13307,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,13308,0)
 ;;=N18.2^^53^589^14
 ;;^UTILITY(U,$J,358.3,13308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13308,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,13308,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,13308,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,13309,0)
 ;;=N18.3^^53^589^15
 ;;^UTILITY(U,$J,358.3,13309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13309,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,13309,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,13309,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,13310,0)
 ;;=N18.4^^53^589^16
 ;;^UTILITY(U,$J,358.3,13310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13310,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,13310,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,13310,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,13311,0)
 ;;=N18.5^^53^589^17
 ;;^UTILITY(U,$J,358.3,13311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13311,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,13311,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,13311,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,13312,0)
 ;;=Q61.3^^53^589^80
 ;;^UTILITY(U,$J,358.3,13312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13312,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,13312,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,13312,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,13313,0)
 ;;=N20.1^^53^589^9
 ;;^UTILITY(U,$J,358.3,13313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13313,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,13313,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,13313,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,13314,0)
 ;;=N18.9^^53^589^18
 ;;^UTILITY(U,$J,358.3,13314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13314,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,13314,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,13314,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,13315,0)
 ;;=N18.6^^53^589^28
 ;;^UTILITY(U,$J,358.3,13315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13315,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,13315,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,13315,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,13316,0)
 ;;=N52.9^^53^589^44
 ;;^UTILITY(U,$J,358.3,13316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13316,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,13316,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,13316,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,13317,0)
 ;;=N32.81^^53^589^75
 ;;^UTILITY(U,$J,358.3,13317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13317,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,13317,1,4,0)
 ;;=4^N32.81
